Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Dabrafenib mesylate when the patent is expiring in india?Symbravo ingredients mechanism of action?Atorvastatin side effects heart palpitations?Abbvie humira patent cliff navigation success?How to apply for vascepa's patient assistance?
See the DrugPatentWatch profile for palynziq
Palynziq (pegvaliase) is used to treat adults with phenylketonuria (PKU). It’s prescribed for people whose blood phenylalanine levels are not adequately controlled by existing dietary management and/or other available treatments. [1]
Palynziq is an enzyme treatment. It helps break down phenylalanine, the substance that builds up in PKU, which lowers blood phenylalanine levels. [1]
The provided information specifies Palynziq use for PKU in adults with uncontrolled blood phenylalanine levels despite other management options. [1]
It is intended for adults with PKU when phenylalanine levels remain too high even with dietary management and/or other treatments. [1]
The goal is to reduce elevated blood phenylalanine levels in adults with PKU who are not adequately controlled with other treatments. [1] Sources: [1] https://www.drugs.com/palynziq.html
Other Questions About Palynziq :